@FierceMedDev: Report: Life Tech may have found a buyer after all. Story | Follow @FierceMedDev
@MarkHFierce: Royalty financing may not be new, but it's novel for the medical device world. More | Follow @MarkHFierce
@DamianFierce: Boston Scientific is holding back some data on Watchman, and market watchers are a little spooked. Report | Follow @DamianFierce
> With CE mark in hand, Medtronic ($MDT) is kicking off the European launch of its Attain Performa portfolio of quadripolar leads, designed to fit its CRT-D devices. News
> Boston Scientific ($BSX) has launched two new sizes of its Rubicon Support Catheter, designed to treat peripheral artery disease. More
> Researchers at UCLA have discovered a new genetic risk factor for Alzheimer's that could help diagnose the disease years before it takes effect. Release
> GN Otometrics' ICS Impulse, a bedside ECG for the eye, demonstrated that it can accurately distinguish stroke from other causes of dizziness. Article
> The state-funded Kansas Bioscience Authority is investing $375,000 in local devicemaker Novita Therapeutics, a company that produces dialysis and brain aneurysm technologies. Story
> VisionQuest 20/20 has developed a video game that measures visual acuity and depth perception in schoolchildren, helping to diagnose vision problems that often elude traditional eye tests. Report
Biotech News
@FierceBiotech: Popular yesterday: Theravance: Biotech's big coming-of-age story. Editor's Corner | Follow @FierceBiotech
@JohnCFierce: TauRx adds $10.5M to its unconventional trove of Alzheimer's PhIII cash. News | Follow @JohnCFierce
@RyanMFierce: Engineering issues have stymied the mini DNA sequencer from Oxford Bio. Blogger says the tech chief is angry: Report | Follow @RyanMFierce
> Japan's Ajinomoto pounces on Althea Tech in $175M buyout deal. News
> TauRx adds $10.5M to its trove of unconventional Alzheimer's PhIII cash. Story
> Teva retrenches on troubled MS blockbuster hopeful as partner grabs $43M. More
> Antibiotics outfit Tetraphase offers price range for $75M biotech IPO. Article
Pharma News
@FiercePharma: Longtime Roche chairman Franz Humer is stepping aside. Who's up next? More | Follow @FiercePharma
@EricPFierce: Pfizer building a plant in Saudi Arabia as MENA area becomes of more interest to Big Pharma. Story | Follow @EricPFierce
> Lilly CEO blasts Europe's drug-pricing moves. Story
> Par to pay $45M for off-label Megace marketing. News
Biomarkers News
> Advanced Cell Diagnostics enables cancer immunotherapy biomarker work. Story
> Australian team builds depression blood test around quinolinic acid. More
> Biomarker shines a light on new pathway to target neuroblastoma. Report
> Scripps scientists spot tropical disease marker in urine. Article
> Ignyta, Lieden University team on RA biomarker research. Item
Drug Delivery News
@MichaelGFierce: Yale researchers improve lupus drug with nanogel delivery. More | Follow @MichaelGFierce
> Actium BioSystems puts the heat on cancer with hyperthermic delivery. Report
> Mercator micro-infusion drug delivery catheter snags CE mark. News
> Combo drug, Dx nanomedicine deliver cancer-fighting payload. Article
> West launches intradermal adapter for shallow injections. Item